Lv7
5000 积分 2024-07-18 加入
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
4天前
已完结
Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity
8天前
已完结
cGAS-activated endothelial cell–T cell cross-talk initiates tertiary lymphoid structure formation
8天前
已完结
Stroma-driven inter- and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation
2个月前
已关闭
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunity
4个月前
已关闭
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
5个月前
已完结
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
5个月前
已完结
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
5个月前
已完结
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
5个月前
已完结
Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures
5个月前
已完结
皖公网安备34019202002308
